Effects of soft occlusal appliance therapy for patients with masticatory muscle pain by Kashiwagi, K et al.
Posted at the Institutional Resources for Unique Collection and Academic Archives at Tokyo Dental College,
Available from http://ir.tdc.ac.jp/
Title
Effects of soft occlusal appliance therapy for
patients with masticatory muscle pain
Author(s)
Alternative
Kashiwagi, K; Noguchi, T; Kenichi, F
Journal




This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-
Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/)
which permits unrestricted non-commercial use,
distribution, and reproduction in any medium,





J Dent Anesth Pain Med 2021;21(1):71-80❚https://doi.org/10.17245/jdapm.2021.21.1.71
Effects of soft occlusal appliance therapy for patients 
with masticatory muscle pain
Kosuke Kashiwagi, Tomoyasu Noguchi, Kenichi Fukuda
Division of Special Needs Dentistry and Orofacial Pain, Department of Oral Health and Clinical Science, Tokyo Dental College, Tokyo, 
Japan
Background: The options for stabilization appliance therapy for masticatory muscle pain include soft occlusal 
and hard stabilization appliances. A previous study suggested that hard stabilization appliance therapy was effective 
for patients with local myalgia who developed long facets on their occlusal appliances. The objective of this 
study was to identify patients in whom a soft occlusal appliance should be used to treat masticatory muscle 
pain by analyzing the type of muscle pain present and patient factors that influenced the effectiveness of this 
treatment.
Methods: The study included 42 patients diagnosed with local myalgia or myofascial pain according to the 
Diagnostic Criteria for Temporomandibular Disorders Diagnostic Decision Tree. The analysis of patient factors 
included variables believed to be associated with temporomandibular disorders. First, a temporary screening 
appliance was used for 2 weeks to assess each patient for bruxism during sleep. Soft appliance therapy was 
then started. For each patient, the effectiveness of the appliance was evaluated according to the intensity of 
tenderness during muscle palpation and the treatment satisfaction score at one month after starting treatment.
Results: Data from 37 of the 42 patients were available for analysis. Twenty-five patients reported satisfaction 
with the appliance. In logistic regression analysis, the odds ratio for reduction of facet length was 1.998. Nineteen 
patients showed at least a 30% improvement in the visual analog scale score. The odds ratio for local myalgia 
was 18.148.
Conclusion: Soft appliance therapy may be used in patients with local myalgia. Moreover, patients who develop 
short facets on the appliance surface are likely to be satisfied with soft appliance therapy. Soft appliance therapy 
may be appropriate for patients with local myalgia who develop short facets on their occlusal appliance.
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INTRODUCTION
  While occlusal stabilization appliance therapy has long 
been used to treat masticatory muscle pain, controversy 
remains regarding its efficacy, with some studies 
reporting its effectiveness [1-3] and others concluding a 
lack of significant effect [4,5]. There are also no clear 
standards regarding the choice and use of occlusal 
appliance therapy for patients with masticatory muscle 
pain. The options for stabilization appliances include soft 
occlusal appliances and hard stabilization appliances. 
Although hard stabilization appliance therapy is currently 
recommended [6], soft appliances are frequently used in 
the clinical setting [7,8]. Some studies have reported that 
these appliances relieve masticatory muscle pain [9-13]. 
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In a previous study, we analyzed the patient factors and 
conditions influencing the change in pain using the visual 
analog scale (VAS) and patient satisfaction following 
hard stabilization appliance therapy for masticatory 
muscle pain. We found that (1) a significantly higher 
proportion of patients whose VAS scores did not improve 
had myofascial pain rather than local myalgia, (2) both 
patients with improved VAS scores and those who were 
satisfied had significantly long facets on their occlusal 
appliances, and (3) patients with a high 9-item Patient 
Health Questionnaire (PHQ-9) score for depression were 
less satisfied the with hard appliance and those with a 
high 15-item Patient Health Questionnaire (PHQ-15) 
score for somatic symptoms showed less improvement 
in their VAS score following hard appliance therapy. 
  The objectives of this study were to analyze the type 
of muscle pain and patient factors influencing the 
effectiveness of soft appliances in the treatment of 
masticatory muscle pain, to identify patients in whom a 
soft appliance should be used, and to identify differences 
between soft and hard appliance therapies.
METHODS
1. Subjects
  The study subjects were patients who presented with 
orofacial pain at the Tokyo Dental College Suidobashi 
Hospital between January and October 2017 and were 
diagnosed with local myalgia or myofascial (spreading 
or referred) pain according to the Diagnostic Criteria for 
Temporomandibular Disorders (DC/TMD) diagnostic 
decision tree. The exclusion criteria were age < 18 years; 
moderate or severe systemic disease (American Society 
of Anesthesiologists physical status class III or above), 
missing free-end, temporomandibular joint pain, failure 
to attend hospital appointments, condition deterioration 
necessitating a switch to a different splint, and 
improvement before starting occlusal splint therapy. 
Forty-two (8 men, 34 women) of 47 eligible patients 
agreed to participate and provided written informed 
consent. The study protocol was approved by the ethics 
committee of Tokyo Dental College (ethical clearance 
number 756). 
2. Assessments
  During the initial examination, we assessed the range 
of pain-free mouth opening, the number of tender points 
on muscle palpation, the intensity of tenderness at the 
most tender point during muscle palpation (using VAS), 
the presence or absence of anterior tooth guide, attrition 
with dentin exposure (defined as attrition of the upper 
and lower teeth was consistent and luster was present), 
awareness of sleep bruxism (SB), awareness of awake 
bruxism, muscle fatigue on waking, torus palatinus or 
torus mandibularis, and scalloping of the tongue. The 
temporalis (anterior, middle, and posterior) and masseter 
(origin, body, and insertion) muscles were palpated on 
both sides. The palpation pressure was 1 kgf for 2 s with 
the finger pressure calibrated before palpation using an 
algometer to standardize the pressure. To differentiate the 
types of myalgia involved, whether local myalgia or 
myofascial pain, the pressure duration was increased to 
5 s. Myofascial pain was defined as the presence of 
spreading or referred pain, while local myalgia was 
defined as the presence of neither condition. 
  Other patient factors investigated included sleep 
duration, snoring or apnea, smoking, daily alcohol 
consumption, daily caffeine consumption, daily duration 
of computer use, and scores on three self-administered 
questionnaires, that is, PHQ-9, PHQ-15, and 7-item 
Generalized Anxiety Disorder (GAD-7) assessment for 
anxiety, which are used during DC/TMD axis II 
screening.
3. Temporary screening appliance
  To screen each patient for SB and, if present, to 
determine whether it was the clenching type (based on 
short wear facets) or grinding/mixed type (based on long 
wear facets), a temporary screening appliance was made 
from autopolymerizing resin (Facet Resin, GC 
Corporation, Tokyo, Japan) for use at night. This resin 
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Fig. 1. Occlusal facets present on the appliance. After 2 weeks, the surface
texture was assessed, and the lengths of the facets formed by the 
mandibular canines were measured.
was selected because it combines sufficient strength with 
the appropriate degree of abradability (for facet 
formation). The appliance position was adjusted with 
canine guidance by grinding. In addition, the appliance 
contacted all the teeth equally on the centric occlusion. 
The appliance was adjusted repeatedly over several days 
until the subject ceased to experience any discomfort. 
After the adjustment was complete, a marker (Facet Resin 
Marker, GC Corporation) was applied to allow for easy 
observation of the surface texture of the appliance. After 
2 weeks, the surface texture was assessed and the lengths 
of the facets formed by the mandibular canines were 
measured. Fig. 1 shows the length of the facets. 
4. Analysis of heart rate variability 
  After 5 min of rest in a quiet, temperature-controlled 
room, the subjects performed a simple standing test that 
included sitting for 2 minutes, standing upright for 2 
minutes, and then sitting again for 1 min. During the test, 
the brachial blood pressure and pulse rate were measured 
with 1-min intervals oscillometrically using blood 
pressure and an electrocardiogram device (Kiritsu 
Meijin®; Crosswell, Kanagawa, Japan). Power spectral 
analysis of variability in the R-R interval reveals both 
low (0.04–0.15 Hz) and high-frequency (0.15–0.4 Hz) 
spectral components. Evidence suggests that high- 
frequency (HF) power is largely a function of 
parasympathetic nervous activity in the heart. Low 
frequency (LF) power is used, most often normalized for 
total power, as a representative index of sympathetic 
activity in the heart [14,15]. The following variables were 
evaluated: the coefficient of component variation for high 
frequency (CCVHF = √HF/AVG (RR) × 100, related to 
parasympathetic activity), the ratio of LF to HF (LF/HF, 
related to sympathetic activity); the coefficient of 
variation of the R-R interval (CVRR, related to autonomic 
nervous system activity); and heart rate (HR) [16,17]. 
5. Soft appliance therapy
  After screening, a soft occlusal appliance was provided 
for use at night. The soft appliance was 2 mm in thickness, 
designed to cover the entire maxillary dentition, and was 
adjusted by tapping until it contacted all teeth equally. 
The subjects were required to attend appointments at the 
hospital for adjustment every 2 weeks.
6. Evaluation of effectiveness of occlusal appliance 
therapy 
  One month after the start of treatment, the effectiveness 
of the occlusal appliance was evaluated using the VAS 
score indicating the intensity of tenderness during muscle 
palpation, The treatment satisfaction score was also 
measured. A VAS score ≥ 30% or a score that was lower 
after treatment than before was considered an 
improvement, while any other score was considered a 
lack of improvement [18]. Treatment satisfaction was 
self-assessed as (1) greatly worsened, (2) worsened, (3) 
no change, (4) improved, or (5) greatly improved. Scores 
of 1, 2, or 3 indicated dissatisfaction, while scores of 4 
or 5 indicated satisfaction. 
7. Statistical analysis
  We compared the patients who exhibited improvement 
to those who did not, and those who expressed satisfaction 
to those who did not in terms of multiple patient factors 
at baseline. Chi-squared tests were used to compare sex, 
presence or absence of myofascial pain, presence or absence 
of anterior tooth contact, attrition with dentin exposure, 
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Fig. 2. The VAS scores and tender points before and after treatment. 
The VAS scores and the numbers of tender points before and 1 month 
after soft appliance therapy. (a) The VAS scores were significantly 
improved. (b) The number of tender points was significantly improved.
Fig. 3. The flow diagram of this study.
awareness of awake bruxism, torus palatinus or torus 
mandibularis, scalloping of the tongue, snoring or apnea, 
smoking, daily alcohol consumption, and daily caffeine 
consumption between groups. Mann–Whitney U tests were 
used to compare age; baseline VAS score (before treatment); 
number of tender points; and 9-item Patient Health 
Questionnaire, PHQ-15, and GAD-7 scores before and 
after standing measurements of HR, CVRR, CCVHF, and 
LF/HF. Student’s t-tests were used to compare sleep 
duration at baseline, daily duration of computer use, range 
of pain-free mouth opening, and facet length (in the canine 
region of the screening appliance).
  Variables that differed significantly in any of these 
comparisons were entered into a logistic regression 
analysis to identify factors predictive of improvement in 
VAS scores and factors associated with satisfaction. All 
statistical analyses were performed using IBM SPSS 
Statistics for Windows, version 24.0 (IBM Corp., 
Armonk, NY, USA). P-values < 0.05 were considered 
statistically significant.
  Wilcoxon signed-rank tests were used to compare the 
changes in VAS scores and the number of tender points 
between before and after soft appliance therapy.
  The target sample size in this case-control study was 
37 patients as this number was deemed sufficient for 
detecting differences with a power of 0.8 based on the 
results of our previous study [19].
RESULTS
  Five of the 42 patients who consented to participate 
in the study were excluded due to failure to attend a
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Table 1. Satisfied and dissatisfied groups
Factors Satisfied Dissatisfied P value
Number of cases 25 12
Male/Female 4/21 4/8 0.231
Age (years) 53.2 ± 12.7 47.6 ± 12.0 0.678
Local myalgia/myofascial pain 12/13 2/10 0.066
Mouth opening range (mm)        41.3 ± 5.6          45.1 ± 6.7 0.066
VAS (before therapy, mm) 51.9 ± 20.7 63.6 ± 19.9  0.041*
Tender points (before therapy) 4.5 ± 2.4 5.1 ± 2.3 0.222
Anterior tooth guide (yes/no) 13/12 4/8 0.286
Tooth wear (attrition) (yes/no) 21/4 12/0 0.142
Tooth grinding (during sleep）(yes/no) 8/17 5/7 0.711
Awake bruxism (yes/no) 16/9 5/7 0.192
Torus mandibularis/palatinus (yes/no) 9/16 6/6 0.416
Tongue scalloping (yes/no) 15/10 8/4 0.695
Snoring or apnea (yes/no) 4/21 2/10 0.959
Smoking (yes/no) 1/24 2/10 0.186
Daily alcohol consumption (yes/no) 5/20 3/9 0.729
Daily caffeine consumption (yes/no) 17/8 4/8 0.127
Sleep duration (hours) 6.3 ± 1.1 6.3 ± 0.6 0.505
Computer use (hours) 2.8 ± 3.5 4.5 ± 3.8 0.096
PHQ-9 7.8 ± 4.3 9.3 ± 8.9 0.568
PHQ-15 7.3 ± 4.6 7.7 ± 6.0 0.513
GAD-7 6.8 ± 4.6  7 ± 5.2 0.464
HR difference (before and after standing) 5.9 ± 6.4 7.1 ± 3.1 0.226
CVRR difference (before and after standing) 1.9 ± 2.1 1.8 ± 1.2 0.534
CCVHF difference (before and after standing)         -0.2 ± 0.7 0.1 ± 0.2 0.069
LH/HF difference (before and after standing)  5.9 ± 12.7 3.9 ± 7.4 0.508
Facet length (mm) 2.7 ± 1.8 4.6 ± 2.1  0.007*
*P < 0.05
VAS, visual analog scale; PHQ-9, 9-item Patient Health Questionnaire; PHQ-15, 15-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety 
Disorder; HR, heart rate; CVRR, coefficient of variation of the R-R interval; CCVHF, coefficient of component variation for high frequency, LH/HF, ratio 
of LF to HF.
hospital appointment (n = 3) or because their condition 
improved before starting stabilization appliance therapy 
(n = 2). Thus, the analysis included 37 patients (eight 
men, 29 women) with a mean age of 48.3 ± 15.2 years. 
The mean ages of the men and women were 50.4 ± 11.3 
and 53.9 ± 13.1 years, respectively. The VAS scores (P 
< 0.00001) and the number of tender points (P < 0.001) 
improved significantly following soft appliance therapy 
(Fig. 2). Fig. 3 illustrates the flow diagram of the study 
design.  
1. Satisfaction versus dissatisfaction
  Twenty-five patients (67.5%) reported satisfaction 
(four men, 21 women; mean age 53.2 ± 12.7 years), while 
12 patients reported dissatisfaction (four men, eight 
women; mean age 47.6 ± 12 years).
  The VAS score at baseline was significantly higher in 
the satisfied patients than that in the dissatisfied patients 
(P = 0.041). The facet length in the satisfied group was 
significantly shorter than that in the dissatisfied group (P 
= 0.007; Table 1). Logistic regression analysis of these 
factors showed an odds ratio for satisfaction with the 
reduction of facet length of 1.998 (Table 2).
2. Improvement versus lack of improvement
  Improvement was evident in 19 (51.3%) patients (four 
men, 15 women; mean age 56.8 ± 14 years) but not in 
the remaining 18 patients (four men, 14 women; mean 
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Table 2. Factors contributing to patient satisfaction
Factors OR 95％CI 　P value
VAS 1.046 0.998–1.096 0.06
Facet length 1.998 1.128–3.539  0.018
OR, odds ratio; CI, confidence interval; VAS, visual analog scale.
Table 3. Improvement and lack of improvement groups
Factors Improvement Lack of improvement P value
Number of cases 19 18
Male/female 4/15 4/14 0.931
Age (years) 56.8 ± 14 49.1 ± 11.2 0.03*
Local myalgia/myofascial pain 11/8 3/15 0.009*
Mouth opening range (mm) 41.8 ± 5.8         44.1 ± 6.9 0.126
VAS (before therapy)  50.8 ± 21.1 61.0 ± 19.9 0.071
Tender points (before therapy)  4.5 ± 2.6 4.7 ± 2.1 0.371
Anterior tooth guide (yes/no) 11/8 6/12 0.134
Tooth wear (attrition) (yes/no) 14/5 17/1 0.117
Tooth grinding (during sleep）(yes/no) 7/12 5/13 0.556
Awake bruxism (yes/no) 13/6 8/10 0.142
Torus mandibularis/palatinus (yes/no) 7/12 6/12 0.823
Tongue scalloping (yes/no) 12/7 11/7 0.897
Snoring or apnea (yes/no) 3/16 3/15 0.942
Smoking (yes/no) 1/18 2/16 0.515
Daily alcohol consumption (yes/no) 5/14 3/15 0.476
Daily caffeine consumption (yes/no) 11/8 10/8 0.419
Sleep duration (hours)  6.4 ± 1.2 6.2 ± 0.7 0.28
Computer use (hours)  3.2 ± 3.9 3.6 ± 3.4 0.261
PHQ-9  6.9 ± 3.8 9.8 ± 6.7 0.275
PHQ-15 5.9 ± 4 9.1 ± 5.4 0.038*
GAD-7 5.6 ± 4 8.8 ± 5.2 0.028*
HR difference (before and after standing)  5.9 ± 3.4 6.7 ± 2.9 0.218
CVRR difference (before and after standing)  1.7 ± 1.5  2 ± 1.2 0.254
CCVHF difference (before and after standing) -0.1 ± 0.3 -0.1 ± 0.3 0.378
LH/HF difference (before and after standing)  6.1 ± 14.3 3.9 ± 2.1 0.269
Facet length (mm) 2.6 ± 2.0 4.0 ± 2.0 0.024*
*P < 0.05
VAS, visual analog scale; PHQ-9, 9-item Patient Health Questionnaire; PHQ-15, 15-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety 
Disorder; HR, heart rate; CVRR, coefficient of variation of the R-R interval; CCVHF, coefficient of component variation for high frequency, LH/HF, ratio 
of LF to HF.
age 49.1 ± 11.2 years).
  The patients who had improved were significantly 
older than those who did not (P = 0.03). Myofascial pain 
was significantly more common in patients who did not 
improve than in those who did improve (P = 0.009). 
Furthermore, the PHQ-15 and GAD-7 scores were 
significantly higher in the patients who did not improve 
than in those who did improve (P = 0.038 and P = 0.028, 
respectively). Facet lengths in the patients who improved 
were significantly shorter than those in patients who did 
not (P = 0.024 L; Table 3). Logistic regression analysis 
showed an odds ratio for improvement of local myalgia 
of 18.148 (Table 4).
DISCUSSION
  Masticatory muscle pain in TMD develops as a result 
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Table 4. Factors contributing to pain improvement
Factors OR 95％CI 　P value
Age  0.956 0.885–1.032  0.247
Local myalgia/Myofascial pain 18.148   1.564–210.595 0.02
PHQ-15  1.003 0.789–1.277  0.978
GAD-7  1.268 0.934–1.723  0.128
Facet length  1.536 0.917–2.572  0.103
OR, odds ratio; CI, confidence interval; PHQ-15, 15-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety Disorder.
of the complex interaction of multiple factors; thus, 
control groups should ideally comprise of patients with 
TMD who fulfill diagnostic criteria similar to those used 
in the treatment groups (with regards to axes I and II 
of the DC/TMD). However, ensuring consistency in these 
criteria is extremely difficult. Therefore, we did not 
include a control group. Instead, we divided the patients 
according to the treatment effect and investigated the 
differences in patient factors between these groups. 
Therefore, a limitation of this study was the lack of 
investigation of the placebo effect. 
  In the present study, local myalgia was improved by 
18-fold compared to myofascial pain on the VAS. 
Myofascial pain is characterized by deep or spreading 
pain and is associated with factors such as central 
sensitization, impaired peripheral blood flow (hypoxia), 
and the pain-inducing action of nerve growth factors that 
can result in sensitivity to palpation or tenderness as a 
result of pressure, sometimes with referred pain [20]. A 
recent study showed that autonomous contractions of the 
fascia may be induced by enhanced sympathetic activity 
and are caused by the release of calcium [21]. These 
studies have also identified myofascial pain and local 
myalgia as distinct entities. A previous study reported a 
50-fold improvement in local myalgia compared to 
myofascial pain when a hard appliance [19]. Myofascial 
pain is a condition different from local myalgia. Local 
myalgia is caused by muscle fatigue; thus, soft and hard 
appliances are likely to be more effective for local 
myalgia than for myofascial pain. The existence of 
psychosocial risk factors and the potential involvement 
of central hyperalgesia must be considered when 
managing myofascial pain. This study has a limited 
patient observation period and observed few side effects 
or complications of discomfort. However, the evaluation 
was performed after 1 month, which was defined as the 
observation period for this study. Thus, long-term side 
effects or discomfort from the soft appliance are also 
possible.
  The shorter facets of soft appliances led to high levels 
of patient satisfaction. However, a study using a similar 
method reported that the use of a hard appliance with 
long facets was also associated with a high level of 
satisfaction [19]. These results are in contrast with our 
finding that patients Please check this unitwith a short 
facet type were more likely to be satisfied with a soft 
appliance, while patients with a long facet type were more 
likely to be satisfied with a hard appliance. These findings 
suggest that a soft appliance works without hindering 
short facets while a hard appliance works without 
hindering the long facets. Thus, unencumbered SB may 
enhance patient satisfaction. Although excessive SB may 
cause muscle pain. One study reported that patients with 
muscle pain showed less muscle activity during sleep 
compared to the controls [22] and another report reported 
decreased muscle activity if pain was present [23]. These 
findings have led to negative opinions regarding the onset 
of muscle pain attributed to excessive SB in recent years. 
If SB is regarded as an opportunity to dissipate stress 
during sleep, then allowing SB to proceed unhindered 
may yield greater comfort.
  Stabilization appliance therapy currently involves the 
use of various devices in clinical practice, with the 
stabilization-type hard appliance preferred for occlusion 
and temporomandibular joints [24]. Previous reports 
showed that soft appliances increased muscle activity and 
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produced more subjective muscle fatigue compared to 
hard appliances [6] and, thus, these devices were not 
recommended [25]. However, these reports do not 
describe the mitigation of pain or perceived patient 
satisfaction with the use of a soft appliance. Pain and 
muscle tenderness were significantly decreased in patients 
who wore a soft appliance compared to controls [10] and 
74% of patients who used a soft appliance reported 
decreases muscle pain [13]. Furthermore, a previous study 
demonstrated similar reductions in muscle tenderness 
between soft and hard appliances and no significant 
difference in VAS pain scores between the two devices 
[11]. These reports and our present results suggest that 
the use of soft appliances may need to be reconsidered 
in the treatment of muscle pain.
  Psychosocial factors affect the risk of chronic 
masticatory muscle pain in TMD [26-28]. Recent studies 
have shown that the PHQ-15 is a valuable tool for 
evaluating somatic symptoms, and the tool is 
recommended in the Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition (DSM-5) [29]. Studies 
of somatic symptoms and masticatory muscle pain in 
TMD have reported a strong association between a high 
score on the PHQ-15 and TMD development [30]. The 
GAD-7 is a valuable screening tool for anxiety. A recent 
study reported that patients with masticatory muscle pain 
in chronic TMD tended to have higher rates of depression 
and anxiety compared to those in the control patients 
[28,31]. Thus, it is important to consider whether anxiety 
may cause chronic pain to become severe. We found no 
difference in PHQ-15 and GAD-7 scores between patients 
who improved and those who did not or between satisfied 
and dissatisfied patients. Nevertheless, the PHQ-15 and 
GAD-7 are considered to be essential in the management 
of masticatory muscle pain in TMD. 
  A relationship between myofascial TMD and the 
autonomic nervous system has been reported, with 
decreased parasympathetic nervous activity and increased 
sympathetic nervous activity during sleep [32]. Patients 
with chronic TMD also showed increased HR and 
autonomic nervous dysfunction, including decreased 
parasympathetic nervous activity [33]. However, the 
autonomic nervous system failed to predict or contribute 
to the incidence of masticatory muscle pain in TMD [34]. 
We observed no difference in autonomic nervous system 
activity between patients who improved and those who 
did not or between satisfied and dissatisfied patients; 
however, we did not distinguish between myalgia and 
myofascial pain. Our findings suggest the need to 
investigate HR variability in patients with myofascial 
pain.
  In conclusion, the results of this study suggested that 
patients with local myalgia responded better to soft 
appliance therapy compared to hard appliance therapy. 
Patients who developed short facets were likely to be 
satisfied with a soft appliance rather than a hard 
appliance. Therefore, a soft appliance may be appropriate 
for patients with local myalgia who develop short facets 
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